JAMA (Journal of the American Medical Association)
Kanalga Telegram’da o‘tish
All the latest articles published on JAMA before going in to print Discussion Group https://t.me/Medical_Professionals_Forum Contact us https://t.me/Contact_Updates_in_Medicine_Bot
Ko'proq ko'rsatish📈 Telegram kanali JAMA (Journal of the American Medical Association) analitikasi
JAMA (Journal of the American Medical Association) (@jamaupdates) Ingliz til segmentidagi kanali faol ishtirokchi. Hozirda hamjamiyat 16 191 obunachidan iborat bo'lib, Tibbiyot toifasida 1 482-o'rinni va AQSH mintaqasida 2 326-o'rinni egallagan.
📊 Auditoriya ko‘rsatkichlari va dinamika
невідомо sanasidan buyon loyiha tez o‘sib, 16 191 obunachiga ega bo‘ldi.
27 Avgust, 2026 dagi oxirgi ma’lumotlarga ko‘ra kanal barqaror faollikka ega. Oxirgi 30 kunda obunachilar soni 343 ga, so‘nggi 24 soatda esa 12 ga o‘zgardi va umumiy qamrov yuqori darajada qolmoqda.
- Tasdiqlash holati: Tasdiqlanmagan
- Jalb etish (ER): Auditoriya o‘rtacha 4.27% darajada jalb etiladi. Nashrdan keyingi dastlabki 24 soatda kontent odatda umumiy obunachilar sonining 2.07% ini tashkil etuvchi reaksiyalarni to‘playdi.
- Post qamrovi: Har bir post o‘rtacha 691 marta ko‘riladi; birinchi sutkada odatda 335 ta ko‘rish yig‘iladi.
- Reaksiyalar va o‘zaro ta’sir: Auditoriya faol: har bir postga o‘rtacha 1 ta reaksiya keladi.
- Tematik yo‘nalishlar: Kontent patient, disease, treatment, drug, guideline kabi asosiy mavzularga jamlangan.
📝 Tavsif va kontent siyosati
Muallif resursni shaxsiy fikrni ifoda etish maydoni sifatida ta’riflaydi:
“All the latest articles published on JAMA before going in to print
Discussion Group
https://t.me/Medical_Professionals_Forum
Contact us
https://t.me/Contact_Updates_in_Medicine_Bot”
Yuqori yangilanish chastotasi (oxirgi ma’lumot 28 Avgust, 2026 da olingan) sababli kanal doimo dolzarb va katta qamrovli bo‘lib qoladi. Analitika auditoriya kontent bilan faol hamkorlik qilishini, uni Tibbiyot toifasidagi muhim ta’sir nuqtasiga aylantirishini ko‘rsatadi.
16 191
Obunachilar
+1224 soatlar
+827 kunlar
+34330 kunlar
Ma'lumot yuklanmoqda...
O'xshash kanallar
Taglar buluti
Kirish va chiqish esdaliklari
---
---
---
---
---
---
Obunachilarni jalb qilish
Avgust '26
Avgust '26
+325
0 kanalda
Iyul '26
+440
0 kanalda
Get PRO
Iyun '26
+422
0 kanalda
Get PRO
May '26
+584
0 kanalda
Get PRO
Aprel '26
+437
0 kanalda
Get PRO
Mart '26
+217
0 kanalda
Get PRO
Fevral '26
+247
0 kanalda
Get PRO
Yanvar '26
+321
0 kanalda
Get PRO
Dekabr '25
+277
0 kanalda
Get PRO
Noyabr '25
+366
2 kanalda
Get PRO
Oktabr '25
+164
0 kanalda
Get PRO
Sentabr '25
+12
0 kanalda
Get PRO
Avgust '25
+29
0 kanalda
Get PRO
Iyul '25
+30
0 kanalda
Get PRO
Iyun '25
+17
0 kanalda
Get PRO
May '25
+9
0 kanalda
Get PRO
Aprel '25
+5
0 kanalda
Get PRO
Mart '25
+17
0 kanalda
Get PRO
Fevral '25
+12
0 kanalda
Get PRO
Yanvar '25
+18
1 kanalda
Get PRO
Dekabr '24
+237
0 kanalda
Get PRO
Noyabr '24
+1 122
0 kanalda
Get PRO
Oktabr '24
+1 120
0 kanalda
Get PRO
Sentabr '24
+1 527
1 kanalda
Get PRO
Avgust '24
+1 128
1 kanalda
Get PRO
Iyul '24
+1 216
0 kanalda
Get PRO
Iyun '24
+781
1 kanalda
Get PRO
May '24
+797
1 kanalda
Get PRO
Aprel '24
+808
1 kanalda
Get PRO
Mart '24
+821
2 kanalda
Get PRO
Fevral '24
+753
1 kanalda
Get PRO
Yanvar '24
+768
0 kanalda
Get PRO
Dekabr '23
+716
1 kanalda
Get PRO
Noyabr '23
+96
1 kanalda
Get PRO
Oktabr '23
+86
0 kanalda
Get PRO
Sentabr '23
+73
0 kanalda
Get PRO
Avgust '23
+90
0 kanalda
Get PRO
Iyul '23
+107
0 kanalda
Get PRO
Iyun '23
+105
0 kanalda
Get PRO
May '23
+169
0 kanalda
Get PRO
Aprel '23
+128
0 kanalda
Get PRO
Mart '23
+84
0 kanalda
Get PRO
Fevral '23
+75
0 kanalda
Get PRO
Yanvar '23
+71
0 kanalda
Get PRO
Dekabr '22
+74
0 kanalda
Get PRO
Noyabr '22
+149
0 kanalda
Get PRO
Oktabr '22
+90
0 kanalda
Get PRO
Sentabr '22
+138
0 kanalda
Get PRO
Avgust '22
+77
0 kanalda
Get PRO
Iyul '22
+50
0 kanalda
Get PRO
Iyun '22
+96
0 kanalda
Get PRO
May '22
+75
0 kanalda
Get PRO
Aprel '22
+80
0 kanalda
Get PRO
Mart '22
+65
0 kanalda
Get PRO
Fevral '22
+26
0 kanalda
Get PRO
Yanvar '22
+56
0 kanalda
Get PRO
Dekabr '21
+44
0 kanalda
Get PRO
Noyabr '21
+39
0 kanalda
Get PRO
Oktabr '21
+61
0 kanalda
Get PRO
Sentabr '21
+66
0 kanalda
Get PRO
Avgust '21
+65
0 kanalda
Get PRO
Iyul '21
+96
0 kanalda
Get PRO
Iyun '21
+120
0 kanalda
Get PRO
May '21
+130
0 kanalda
Get PRO
Aprel '21
+812
0 kanalda
| Sana | Obunachilarni jalb qilish | Esdaliklar | Kanallar | |
| 28 Avgust | +4 | |||
| 27 Avgust | +12 | |||
| 26 Avgust | +16 | |||
| 25 Avgust | +3 | |||
| 24 Avgust | +7 | |||
| 23 Avgust | +9 | |||
| 22 Avgust | +12 | |||
| 21 Avgust | +24 | |||
| 20 Avgust | +15 | |||
| 19 Avgust | +11 | |||
| 18 Avgust | +10 | |||
| 17 Avgust | +17 | |||
| 16 Avgust | +7 | |||
| 15 Avgust | +14 | |||
| 14 Avgust | +14 | |||
| 13 Avgust | +9 | |||
| 12 Avgust | +14 | |||
| 11 Avgust | +19 | |||
| 10 Avgust | +7 | |||
| 09 Avgust | +15 | |||
| 08 Avgust | +18 | |||
| 07 Avgust | +2 | |||
| 06 Avgust | +16 | |||
| 05 Avgust | +5 | |||
| 04 Avgust | +13 | |||
| 03 Avgust | +11 | |||
| 02 Avgust | +9 | |||
| 01 Avgust | +12 |
Kanal postlari
Nomenclature
https://jamanetwork.com/journals/jama/fullarticle/2853365
In this narrative medicine essay, a maternal-fetal medicine physician trained to use clinical terms for developmental stages of pregnancy as an emotional stay against an uncertain outcome experiences tension between clinical and lived language during his wife’s miscarriage.
| 2 | ADVOCATing for Patients With Heart Failure
https://jamanetwork.com/journals/jama/fullarticle/2853366
The ADVOCATE initiative and how autonomous AI agents could help patients with heart failure are discussed by JAMA+ AI Editor in Chief Roy Perlis, MD, MSc, and Haider Warraich, MD, a cardiologist and the program manager at ARPA-H, for the JAMA+ AI Conversations podcast. | 294 |
| 3 | Parental Support Package for Pregnant and Postpartum Trainees—Reply
https://jamanetwork.com/journals/jama/fullarticle/2853367
In Reply We share the conviction of Dr Patek and colleagues that parental leave is critically important for the well-being of childbearing trainees. We believe, however, that burnout among childbearing trainees is multifactorial, and the empirical evidence does not support paid parental leave as the single most important intervention to reduce burnout in this population. While foundational, leave policies do not address many stressors that emerge during pregnancy or after trainees return to clinical work. As Patek and colleagues note, regardless of leave duration, trainees ultimately transition back to work, and support is needed when they do. | 285 |
| 4 | Parental Support Package for Pregnant and Postpartum Trainees
https://jamanetwork.com/journals/jama/fullarticle/2853368
To the Editor The recent article on a pragmatic parental support package to mitigate burnout among pregnant and postpartum trainees addressed a real and underrecognized problem. However, the proposed parental support package did not address the structural determinants of burnout in this population, and framing it as a meaningful solution risks diverting attention from reforms with greater demonstrated impact. | 256 |
| 5 | Foreign Letters
https://jamanetwork.com/journals/jama/fullarticle/2853369 | 233 |
| 6 | Amoxicillin-Clavulanate vs Amoxicillin for Sinusitis
https://jamanetwork.com/journals/jama/fullarticle/2853349
To the Editor Dr Savage and colleagues reported no difference in treatment failure between standard-dose amoxicillin-clavulanate and amoxicillin among adults aged 18 to 64 years treated for outpatient acute sinusitis, whereas amoxicillin-clavulanate was associated with higher risks of yeast infection and Clostridioides difficile infection. These findings are important for antimicrobial stewardship and support narrower-spectrum therapy when antibiotics are indicated for uncomplicated acute sinusitis. | 552 |
| 7 | Amoxicillin-Clavulanate vs Amoxicillin for Sinusitis
https://jamanetwork.com/journals/jama/fullarticle/2853350
To the Editor The retrospective cohort study by Dr Savage and colleagues compared outcomes of narrow- vs broader-spectrum antibiotics for acute sinusitis. Although the authors’ findings support use of amoxicillin when antibiotics are prescribed, the underlying assumption that most patients truly had acute bacterial sinusitis warrants closer scrutiny. | 521 |
| 8 | Cannabinoid Hyperemesis Syndrome
https://jamanetwork.com/journals/jama/fullarticle/2853351
This JAMA Insights discusses cannabinoid hyperemesis syndrome, including pathophysiology, clinical presentation, and the epidemiology and risk factors. | 460 |
| 9 | Revised Supplement 2
https://jamanetwork.com/journals/jama/fullarticle/2853352
The Original Investigation titled “Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis,” published on October 3, 2023, was corrected to update Supplement 2. In the original supplement, eTable 21 and eTable 22 were identical and did not have the correct information. This article was corrected online. | 422 |
| 10 | Venous Thromboembolism Risk and Lipid-Lowering Therapy
https://jamanetwork.com/journals/jamacardiology/fullarticle/2853339
To the Editor The post hoc analysis of the CLEAR Outcomes trial by Spiazzi and colleagues provides a clinically stimulating observation: bempedoic acid was associated with a 42% relative reduction in venous thromboembolism (VTE) among statin-intolerant patients at high cardiovascular risk or with established cardiovascular disease. This quantitative signal is particularly relevant because VTE, encompassing deep vein thrombosis and pulmonary embolism, remains a frequent and potentially severe condition, associated with substantial morbidity, mortality, recurrence, and health care burden. | 445 |
| 11 | Bleeding and Stroke Prevention After Left Atrial Appendage Occlusion
https://jamanetwork.com/journals/jamacardiology/fullarticle/2853340
To the Editor Schmidt et al provide informative, long-term data on major bleeding (MB) after left atrial appendage occlusion (LAAO). However, several aspects merit further discussion in the context of the evolving use of LAAO and contemporary postprocedural management. | 355 |
| 12 | Left Atrial Systolic Collapse in Cardiac Tamponade
https://jamanetwork.com/journals/jamacardiology/fullarticle/2853341
This case report discusses cardiac tamponade identified through left atrial collapse in a woman in her late 60s with a history of hypertension and diabetes who presented with progressive dyspnea and chest pain. | 341 |
| 13 | Vutrisiran and Transthyretin Amyloidosis With Cardiomyopathy
https://jamanetwork.com/journals/jamacardiology/fullarticle/2853333
This post hoc analysis of a randomized clinical trial investigates the association of right ventricular (RV) function with clinical outcomes and evaluates the effect of vutrisiran on measures of RV function. | 323 |
| 14 | Inequities in Age-Related Perinatal Cardiometabolic Risk
https://jamanetwork.com/journals/jamacardiology/fullarticle/2853335
This cross-sectional study quantifies disparities in age-related risk of perinatal cardiometabolic conditions at the intersection of race and ethnicity and socioeconomic status. | 306 |
| 15 | Left Atrial Appendage Occlusion vs Oral Anticoagulation—No Free Lunch
https://jamanetwork.com/journals/jamacardiology/fullarticle/2853343
Atrial fibrillation (AF) is a leading cause of ischemic stroke. Moreover, strokes due to AF are more likely to have larger infarct volume, more frequent hemorrhagic transformation, and more severe disability and mortality. Oral anticoagulation (OAC) is recommended in individuals with AF who are at increased risk for stroke. Although OAC is highly effective at reducing the risk of stroke, adherence to OAC is challenging due to the risk of bleeding, adverse effects like bruising, and financial cost. Transesophageal echocardiography and autopsy data suggest that approximately 90% of embolic strokes in individuals with nonrheumatic AF are due to thrombi that originate in the left atrial appendage. Thus, in theory, percutaneous left atrial appendage occlusion (LAAO) should reduce the risk of ischemic stroke and reduce the risk of bleeding if patients can discontinue OAC. Yet as with any procedure, LAAO has risks, including procedural complications, incomplete seal, device-related thrombus, and a need for postprocedural antithrombotic therapy. The 2023 American College of Cardiology (ACC)/American Heart Association (AHA)/American College of Clinical Pharmacy (ACCP)/Heart Rhythm Society (HRS) guidelines state that percutaneous LAAO may be a reasonable alternative to OAC based on patient preference in those with AF who have a high risk of major bleeding (class 2b). | 427 |
| 16 | Affiliations Updated
https://jamanetwork.com/journals/jama/fullarticle/2853317
The Original Investigation titled “Global Burden of Elevated LDL-C: Findings From the Global Burden of Disease Study 2023,” published July 29, 2026, was corrected to update the author affiliations list. This article was corrected online. | 514 |
| 17 | Health Care Ownership and Patient Care
https://jamanetwork.com/journals/jama/fullarticle/2853252
This Viewpoint discusses how consolidation in frontline care delivery has shaped health care markets across the US and how changes in ownership of hospitals and practices affect clinicians and patient outcomes. | 639 |
| 18 | Postural Orthostatic Tachycardia Syndrome
https://jamanetwork.com/journals/jama/fullarticle/2853253
This review summarizes current evidence on pathophysiology, diagnosis, and management of postural orthostatic tachycardia syndrome (POTS). | 615 |
| 19 | Managing Chronic Subdural Hematoma—Reply
https://jamanetwork.com/journals/jama/fullarticle/2853254
In Reply We thank Dr Madsbu and colleagues for their thoughtful comments regarding our trial and for highlighting the importance of optimizing surgical management in patients with chronic subdural hematoma. | 566 |
| 20 | Managing Chronic Subdural Hematoma
https://jamanetwork.com/journals/jama/fullarticle/2853255
To the Editor Interest in embolization of the middle meningeal artery (EMMA) for chronic subdural hematoma is growing, and the trial by Dr Shankar and colleagues is welcome. The decision to randomize patients to adjuvant embolization after surgical drainage is commendable because it preserves blinding of the surgeon and isolates the effect of embolization from variability in surgical performance. | 498 |
